{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:17:20Z","timestamp":1770481040292,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jcf.2023.03.006","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T05:42:17Z","timestamp":1678772537000},"page":"702-705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between nebuliser therapies adherence and visit-to-visit variability of FEV1 in patients with cystic fibrosis"],"prefix":"10.1016","volume":"22","author":[{"given":"David","family":"Drummond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5351-9960","authenticated-orcid":false,"given":"Matthew","family":"Sperrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2023.03.006_bib0001","unstructured":"European Cystic Fibrosis Society. ECFS patient registry; Annual Data Report 2019."},{"key":"10.1016\/j.jcf.2023.03.006_bib0002","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcf.2023.03.006_bib0003","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2017.01.002","article-title":"Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: a statistical perspective for the clinical researcher","volume":"16","author":"Szczesniak","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.03.006_bib0004","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpeds.2015.08.042","article-title":"Forced expiratory volume in 1\u00a0s variability helps identify patients with cystic fibrosis at risk of greater loss of lung function","volume":"169","author":"Morgan","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2023.03.006_bib0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ppul.21526","article-title":"Lung function decline from adolescence to young adulthood in cystic fibrosis","volume":"47","author":"Vandenbranden","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.03.006_bib0006","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jcf.2019.12.005","article-title":"Rapid lung function decline in adults with early-stage cystic fibrosis lung disease","volume":"19","author":"Dasenbrook","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.03.006_bib0007","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/jhh.2015.26","article-title":"Medication adherence and visit-to-visit variability of systolic blood pressure in African Americans with chronic kidney disease in the AASK trial","volume":"30","author":"Hong","year":"2016","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jcf.2023.03.006_bib0008","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jch.12037","article-title":"Association between antihypertensive medication adherence and visit-to-visit variability of blood pressure","volume":"15","author":"Muntner","year":"2013","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.jcf.2023.03.006_bib0009","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1060028020931806","article-title":"Exploratory analysis of the impact of an mhealth medication adherence intervention on tacrolimus trough concentration variability: post hoc results of a randomized controlled trial","volume":"54","author":"McGillicuddy","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jcf.2023.03.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00987-2016","article-title":"Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis","volume":"49","author":"White","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2023.03.006_bib0011","first-page":"117","article-title":"An overview of the common methods used to measure treatment adherence","volume":"92","author":"Anghel","year":"2019","journal-title":"Med Pharm Rep"},{"key":"10.1016\/j.jcf.2023.03.006_bib0012","article-title":"Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial","author":"Wildman","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2023.03.006_bib0013","doi-asserted-by":"crossref","first-page":"17421","DOI":"10.1038\/s41598-020-74502-1","article-title":"Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry","volume":"10","author":"Earnest","year":"2020","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2023.03.006_bib0014","first-page":"16","article-title":"Moving cystic fibrosis care from rescue to prevention by embedding adherence measurement in routine care","volume":"15","author":"Wildman","year":"2014","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2023.03.006_bib0015","article-title":"S136 Understanding longitudinal changes in%FEV1 variability and its role as an indicator of care quality among adults with cystic fibrosis","volume":"73","author":"El-Gheryani","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2023.03.006_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2022.12.017","article-title":"Corrigendum to FEV1 variability helps identify patients with cystic fibrosis at risk of greater loss of lung Function","author":"Morgan","year":"2023","journal-title":"J Pediatr"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932300070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932300070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:32:52Z","timestamp":1751581972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156919932300070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S156919932300070X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.03.006","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between nebuliser therapies adherence and visit-to-visit variability of FEV1 in patients with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}